# SEO Meta Package — KPV

**Site:** https://peptidemap.com  
**Draft body:** `/workspace/drafts/encyclopedia/kpv.md`  
**Live URL:** `https://peptidemap.com/encyclopedia/kpv`  
**Page type:** single  
**Status:** paste-ready — CAS locked `67727-97-3`; publish hold lifted 2026-09-30. Meta package only; does not edit live site.  
**Prepared:** 2026-09-30 (Asia/Bangkok)
**Light refresh (2026-09-30):** Wired featured/OG image from draft frontmatter; title/meta/H1 re-checked against revised body — **no title/meta/H1 change required** (still accurate). `/guides` + beginner/legality guides now **200**.
  
**Intent:** single-compound encyclopedia — α-MSH C-terminal tripeptide; anti-inflammatory research focus; not a tanning peptide

---
## CAS LOCKED (2026-09-30) — PUBLISH HOLD LIFTED

**Locked CAS:** `67727-97-3` (Colin / Grok Bot). **Never use** `67724-34-9` in titles, metas, schema, or molecularInfo.

- Title/meta/H1 below remain valid; molecularInfo/schema may now cite **67727-97-3** only.
- Body draft `/workspace/drafts/encyclopedia/kpv.md` still shows `casNumber: 67724-34-9` — **Encyclopedia Author must flip body CAS** before CMS paste.
- Status: **paste-ready** for meta fields; coordinate body CAS fix + featured image upload with publish.

## 1. Recommended slug

**Confirm:** `/encyclopedia/kpv`

**Why:** Live `kpv`/`KPV` both **200**; draft cite-us uses lowercase—prefer lowercase canonical.

**Live check (2026-09-30):** **200** thin stub.

**Canonical:** `https://peptidemap.com/encyclopedia/kpv`

---
## 2. SEO title (~60 chars)

**Recommended:** `What is KPV? Lys-Pro-Val Research Tripeptide`  
**Character count:** 44

**Why:** What-is + sequence identity; clear research framing; avoids IBD efficacy claims.
**Runner-ups:**
1. `KPV Peptide (Lys-Pro-Val): Evidence Overview` — **44 chars** — sequence + evidence
2. `KPV: α-MSH Fragment Research Guide` — **34 chars** — mechanism family cue

---
## 3. Meta description (~155 chars)

**Recommended:** `KPV is the Lys-Pro-Val α-MSH fragment studied for anti-inflammatory biology in models—not an FDA-approved IBD drug and not a tanning peptide.`  
**Character count:** 141

**Why:** Identity + research focus + two common misconceptions corrected; no dosing.

**Runner-up (142):** `Educational KPV overview: tripeptide identity, preclinical inflammation research, PepT1 interest, and why KLOW inclusion isn’t clinical proof.`

---
## 4. H1

**Keep; subtitle Lys-Pro-Val (α-MSH C-terminal tripeptide):** `KPV`

**Why:** Matches molecule name/cite-us.

---
## 5. Open Graph + Twitter

**og:type:** `article`  
**og:url / twitter:url:** `https://peptidemap.com/encyclopedia/kpv`  
**og:site_name:** `Peptidemap`  
**og:image / twitter:image (CMS wiring):**  
- Draft/frontmatter asset: `/workspace/drafts/encyclopedia/images/kpv-featured.png`  
- Upload/rel path for CMS: `images/kpv-featured.png`  
- **Do not invent** a live public CDN URL until uploaded; temporary fallback if CMS requires absolute URL pre-upload: `https://peptidemap.com/images/og-default-v7.png`
**OG/Twitter title:** `What is KPV? Lys-Pro-Val Research Tripeptide` (44)

**OG/Twitter description:** `α-MSH residues 11–13 (Lys-Pro-Val): preclinical anti-inflammatory research context—not approved therapy, not Melanotan-style tanning.`  
**Character count:** 133

**Twitter card:** `summary_large_image` (reuse OG).

---
## 6. Keywords
**Primary:**
- KPV peptide
- KPV Lys-Pro-Val
- what is KPV

**Secondary:**
- α-MSH fragment
- KPV inflammation research
- KPV KLOW blend

**Avoid in meta:** dosing, prices, invented efficacy stats, absolute legal verdicts.

---
## 7. Internal link suggestions (verified 2026-09-30)

| Path | Status | Role |
| --- | --- | --- |
| `/encyclopedia/klow-blend-ghk-cu-bpc-157-tb-500-kpv` | **200** | Blend containing KPV |
| `/encyclopedia/Melanotan-II` | **200** | Different melanocortin pharmacology — disambiguation |
| `/encyclopedia` | **200** | Hub |
| `/testing-labs` | **200** | COA |
| `/vendors` | **200** | Directory |

**Soft / blocked:**
- `/guides/peptide-legality-fda-ruo-compounding` — 200: PCAC/compounding literacy

Also useful hubs: `/encyclopedia`, `/compare`, `/testing-labs`, `/vendors` (all **200**).

---
## 8. JSON-LD (FAQPage + Article)

Claims mirror draft FAQs only. No dosing/prices/invented stats.
### FAQPage
```json
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "@id": "https://peptidemap.com/encyclopedia/kpv#faq",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Is KPV a tanning peptide?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No—research focus is anti-inflammatory fragment biology, not MT-II-style tanning."
      }
    },
    {
      "@type": "Question",
      "name": "Is it approved for IBD?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No."
      }
    },
    {
      "@type": "Question",
      "name": "Why is it in KLOW?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Commercial formulation choice adding an anti-inflammatory tripeptide to a GLOW-like trio—not clinical proof."
      }
    }
  ]
}
```
### Article
```json
{
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": "https://peptidemap.com/encyclopedia/kpv#article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://peptidemap.com/encyclopedia/kpv"
  },
  "headline": "KPV",
  "name": "What is KPV? Lys-Pro-Val Research Tripeptide",
  "description": "KPV is the Lys-Pro-Val α-MSH fragment studied for anti-inflammatory biology in models—not an FDA-approved IBD drug and not a tanning peptide.",
  "url": "https://peptidemap.com/encyclopedia/kpv",
  "isPartOf": {
    "@type": "WebSite",
    "name": "Peptidemap",
    "url": "https://peptidemap.com"
  },
  "author": {
    "@type": "Organization",
    "name": "Peptidemap",
    "url": "https://peptidemap.com"
  },
  "publisher": {
    "@type": "Organization",
    "name": "Peptidemap",
    "url": "https://peptidemap.com",
    "logo": {
      "@type": "ImageObject",
      "url": "https://peptidemap.com/images/logo.png"
    }
  },
  "image": [
    "https://peptidemap.com/images/og-default-v7.png"
  ],
  "datePublished": "2026-09-30",
  "dateModified": "2026-09-30",
  "inLanguage": "en-US",
  "keywords": [
    "KPV",
    "Lys-Pro-Val",
    "α-MSH",
    "anti-inflammatory research"
  ],
  "about": [
    {
      "@type": "Thing",
      "name": "KPV"
    },
    {
      "@type": "Thing",
      "name": "α-melanocyte-stimulating hormone"
    }
  ]
}
```
Optional BreadcrumbList: Home → Encyclopedia → this name.

**Schema image note:** Swap Article `image` from site default to published absolute URL for `images/kpv-featured.png` at go-live.

---
## 9. Cite-us awareness

**Suggested cite title:** *KPV*
**Cite URL:** `https://peptidemap.com/encyclopedia/kpv`
**APA (suggested):**
Peptidemap. (2026). *KPV*. Peptidemap Encyclopedia. https://peptidemap.com/encyclopedia/kpv
**Chicago (suggested):**
Peptidemap. "KPV." *Peptidemap Encyclopedia*. 2026. https://peptidemap.com/encyclopedia/kpv.

**Snippet accuracy:** Keep scientific identity (Lys-Pro-Val). Do not cite as approved IBD therapy. Lock CAS/salt only after editor verification noted in draft.

**Access note:** Educational research overview; not a clinical guideline. Verify primary sources before scholarly citation.

---
## 10. Notes for Page Author

1. Disambiguate vs Melanotan-II early.
2. PCAC advisory language if mentioned: not final Bulks List.
3. Confirm molecularInfo CAS/salt before publish.

---
## 11. Publish blockers / Grok Bot flags

- **CAS LOCKED `67727-97-3`** — hold lifted. Body draft still has wrong `67724-34-9`; Encyclopedia Author must update before paste. Never use `67724-34-9`.

- Live page **200** but thin meta (`Comprehensive guide to … peptides.`).
- MolecularInfo CAS/salt still ‘verify’ in draft — flag before schema molecular claims beyond draft text.
- `/guides` + beginner & legality guides now **200** (verified 2026-09-30).

**Shared:** No live-site edits performed by Meta Optimizer; CMS paste only after Colin approval.
